Would we recover better sleep at the end of Covid-19? A relative improvement observed at the population level with the end of the lockdown in France.


Journal

Sleep medicine
ISSN: 1878-5506
Titre abrégé: Sleep Med
Pays: Netherlands
ID NLM: 100898759

Informations de publication

Date de publication:
02 2021
Historique:
received: 30 09 2020
revised: 27 11 2020
accepted: 29 11 2020
pubmed: 11 1 2021
medline: 27 2 2021
entrez: 10 1 2021
Statut: ppublish

Résumé

The outbreak of the Covid-19 pandemic and the accompanying lockdown measures have had a major impact on societies around the world, leading to sleep problems for a large part of the population. In order to assess the sustainability of sleeping troubles related to the sanitary crisis, it was crucial to measure its prevalence after the end of the Covid-19 confinement. As part of an epidemiological survey on Covid and Confinement (COCONEL), we enquired on sleep disorders using two items in 4 repetitive cross-sectional surveys. The first took place during the first week of the French confinement (March 31 to April 2; N = 1005 participants). The second took place in the middle of this period (April 15-17; N = 1005). The two last surveys were held at the end of the confinement (May 7-10; N = 2003) and one month after the end (June 10-12; N = 1736). Using a random constant, the mixed model took into account the longitudinal character of the last two waves (intra-individual correlations for individuals surveyed in waves 3 and 4). The prevalence of sleep problems significantly decreased during the last weeks of the confinement, and this trend was confirmed one month after the end of confinement. One quarter of the population reported that their sleep was better one month after the end of the confinement. Sleep improvement was reported more often by women and people aged less than 65. Such improvement was less frequent among those who were still highly exposed to the pandemic's media coverage after the end of the confinement. The possibility of recovering a good sleep largely depends on the type of sleep disorder. The decrease in sleep problems occurred mainly among people with mild sleep problems during the confinement. Further research is needed to assess the long-term effects of the Covid-19 pandemic and its confinement period on sleep quality in the general population.

Sections du résumé

BACKGROUND
The outbreak of the Covid-19 pandemic and the accompanying lockdown measures have had a major impact on societies around the world, leading to sleep problems for a large part of the population. In order to assess the sustainability of sleeping troubles related to the sanitary crisis, it was crucial to measure its prevalence after the end of the Covid-19 confinement.
METHODS
As part of an epidemiological survey on Covid and Confinement (COCONEL), we enquired on sleep disorders using two items in 4 repetitive cross-sectional surveys. The first took place during the first week of the French confinement (March 31 to April 2; N = 1005 participants). The second took place in the middle of this period (April 15-17; N = 1005). The two last surveys were held at the end of the confinement (May 7-10; N = 2003) and one month after the end (June 10-12; N = 1736). Using a random constant, the mixed model took into account the longitudinal character of the last two waves (intra-individual correlations for individuals surveyed in waves 3 and 4).
RESULTS
The prevalence of sleep problems significantly decreased during the last weeks of the confinement, and this trend was confirmed one month after the end of confinement. One quarter of the population reported that their sleep was better one month after the end of the confinement. Sleep improvement was reported more often by women and people aged less than 65. Such improvement was less frequent among those who were still highly exposed to the pandemic's media coverage after the end of the confinement.
CONCLUSION
The possibility of recovering a good sleep largely depends on the type of sleep disorder. The decrease in sleep problems occurred mainly among people with mild sleep problems during the confinement. Further research is needed to assess the long-term effects of the Covid-19 pandemic and its confinement period on sleep quality in the general population.

Identifiants

pubmed: 33422813
pii: S1389-9457(20)30529-3
doi: 10.1016/j.sleep.2020.11.029
pmc: PMC7722490
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

115-119

Investigateurs

Patrick Peretti-Watel (P)
Valérie Seror (V)
Sébastien Cortaredona (S)
Lisa Fressard (L)
Odile Launay (O)
Jocelyn Raude (J)
Pierre Verger (P)
François Beck (F)
Stéphane Legleye (S)
Olivier L'Haridon (O)
Jeremy Ward (J)
Damien Léger (D)

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Références

J Sleep Res. 2020 Aug;29(4):e13074
pubmed: 32410272
J Thorac Dis. 2020 Oct;12(Suppl 2):S163-S175
pubmed: 33214921
J Sleep Res. 2021 Feb;30(1):e13119
pubmed: 32596936
Sleep Med Rev. 2012 Feb;16(1):5-14
pubmed: 21596596
Sleep. 2020 Oct 13;43(10):
pubmed: 32710627
Neurotherapeutics. 2012 Oct;9(4):687-701
pubmed: 22976557
Med Sci (Paris). 2009 Feb;25(2):201-6
pubmed: 19239854
J Neurol. 2021 Jan;268(1):8-15
pubmed: 32654065
Brain Behav Immun. 2020 Jul;87:56-58
pubmed: 32315758
Sleep Med. 2020 Sep;73:47-52
pubmed: 32771927
Brain Behav Immun. 2020 Jul;87:40-48
pubmed: 32298802
J Sleep Res. 2021 Feb;30(1):e13231
pubmed: 33200477
Neurol Sci. 2020 Aug;41(8):2021-2022
pubmed: 32607852
Brain Behav Immun. 2020 Oct;89:531-542
pubmed: 32485289
Curr Biol. 2020 Jul 20;30(14):R822-R823
pubmed: 32693079
Brain Behav Immun. 2020 Jul;87:84-92
pubmed: 32335200
Int J Environ Res Public Health. 2020 Nov 14;17(22):
pubmed: 33202686
Fam Pract. 1991 Dec;8(4):396-401
pubmed: 1800209
Brain Behav Immun. 2020 Jul;87:74
pubmed: 32325097
Curr Biol. 2020 Jul 20;30(14):R795-R797
pubmed: 32693067
J Sleep Res. 2020 Aug;29(4):e13052
pubmed: 32246787
Front Psychiatry. 2020 Mar 10;11:167
pubmed: 32210854
Psychiatry Res. 2020 May;287:112934
pubmed: 32229390
PLoS One. 2020 Apr 16;15(4):e0231924
pubmed: 32298385
Sleep Med Rev. 2012 Feb;16(1):3-4
pubmed: 22070898
BMJ. 2020 Jan 28;368:m313
pubmed: 31992552

Auteurs

Francois Beck (F)

CESP (Centre de recherche en Épidémiologie et Santé des Populations), Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm U1018, Villejuif, 94807, France.

Damien Leger (D)

Université de Paris, EA 7330 VIFASOM (Vigilance Fatigue Sommeil et Santé Publique), Paris, France; APHP, Hôtel-Dieu, Centre du Sommeil et de la Vigilance, Consultation de pathologie professionnelle Sommeil Vigilance et Travail, Paris, France. Electronic address: damien.leger@aphp.fr.

Sebastien Cortaredona (S)

Southeastern Health Regional Observatory (ORS Paca), Marseille, France.

Pierre Verger (P)

Southeastern Health Regional Observatory (ORS Paca), Marseille, France; AMU, UMR Vitrome, IHU Méditerrannée, IRD, France.

Patrick Peretti-Watel (P)

AMU, UMR Vitrome, IHU Méditerrannée, IRD, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH